Raymond James Financial, Inc.
RJFNYSECIK 720005Financial / Capital Marketsfiscal year ends September69 quarters since 2009
Latest quarter Q3 FY2026, filed August 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of August 5, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Aug 5, 2026 | Q2 FY2026ended Mar 31, 2026filed May 6, 2026 | Q1 FY2026ended Dec 31, 2025filed Feb 6, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025 | Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025 | Q2 FY2025ended Mar 31, 2025filed May 7, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 7, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,928 | 3,859 | 3,735 | 3,727 | 3,398 | 3,403 | 3,537 | 3,462 | +15.6% |
| Cost of revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — |
| Other income (expense) | — | — | — | — | — | — | — | — | — |
| Pretax income | — | — | — | — | 563 | 671 | 749 | — | — |
| Income tax | 155 | 191 | 165 | 127 | 127 | 176 | 149 | 158 | +22.0% |
| Net income | 595 | 544 | 563 | 604 | 436 | 495 | 600 | 602 | +36.5% |
| Diluted EPS ($) | 3.01 | 2.72 | 2.79 | — | 2.12 | 2.36 | 2.86 | — | +42.0% |
| Diluted shares (millions) | 197 | 199 | 201 | — | 206 | 209 | 209 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Aug 5, 2026 | Q2 FY2026ended Mar 31, 2026filed May 6, 2026 | Q1 FY2026ended Dec 31, 2025filed Feb 6, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025 | Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025 | Q2 FY2025ended Mar 31, 2025filed May 7, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 7, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9,977 | 11,219 | 9,890 | 11,389 | 9,195 | 9,662 | 10,048 | 10,998 | +8.5% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — |
| Total assets | 94,237 | 91,944 | 88,760 | 88,230 | 84,815 | 83,132 | 82,282 | 82,992 | +11.1% |
| Total current liabilities | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Total liabilities | 81,454 | 79,334 | 76,186 | 75,726 | 72,554 | 70,905 | 70,353 | 71,325 | +12.3% |
| Stockholders’ equity | 12,699 | 12,567 | 12,570 | 12,503 | 12,259 | 12,212 | 11,923 | 11,673 | +3.6% |
| Shares outstanding (millions) | 192 | 195 | 197 | 197 | 199 | 202 | 205 | 204 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.
| Millions of dollars | Q3 FY2026ended Jun 30, 2026filed Aug 5, 2026 | Q2 FY2026ended Mar 31, 2026filed May 6, 2026 | Q1 FY2026ended Dec 31, 2025filed Feb 6, 2026 | Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025 | Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025 | Q2 FY2025ended Mar 31, 2025filed May 7, 2025 | Q1 FY2025ended Dec 31, 2024filed Feb 7, 2025 | Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | (246) | 1,099 | (10) | 796 | 691 | 117 | 830 | 510 | −135.6% |
| Capital expenditures | 62 | 45 | 46 | 44 | 57 | 46 | 41 | 50 | +8.8% |
| Free cash flow (CFO − capex) | (308) | 1,054 | (56) | 752 | 634 | 71 | 789 | 460 | −148.6% |
| Depreciation and amortization | 55 | 50 | 49 | 52 | 49 | 47 | 47 | 47 | +12.2% |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed November 25, 2025.
Income statement
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 25, 2025 | FY2024ended Sep 30, 2024filed Nov 26, 2024 | FY2023ended Sep 30, 2023filed Nov 21, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 23, 2021 | FY2020ended Sep 30, 2020filed Nov 24, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 21, 2018 | FY2017ended Sep 30, 2017filed Nov 22, 2017 | FY2016ended Sep 30, 2016filed Nov 22, 2016 | FY2015ended Sep 30, 2015filed Nov 25, 2015 | FY2014ended Sep 30, 2014filed Nov 25, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 21, 2012 | FY2011ended Sep 30, 2011filed Nov 23, 2011 | FY2010ended Sep 30, 2010filed Nov 24, 2010 | FY2009ended Sep 30, 2009filed Aug 6, 2010 | FY2008ended Sep 30, 2008filed Aug 6, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,065 | 12,821 | 11,619 | 11,003 | 9,760 | 7,990 | 7,740 | 7,274 | 6,371 | 5,405 | 5,204 | 4,861 | 4,485 | 3,807 | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other income (expense) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pretax income | — | — | 2,280 | 2,022 | 1,791 | 1,052 | 1,375 | 1,311 | 925 | 801 | 798 | 748 | 594 | 468 | 451 | 356 | 236 | 383 |
| Income tax | 579 | 575 | 541 | 513 | 388 | 234 | 341 | 454 | 289 | 271 | 296 | 268 | 197 | 176 | 183 | 134 | 96 | 152 |
| Net income | 2,135 | 2,068 | 1,739 | 1,509 | 1,403 | 818 | 1,034 | 857 | 636 | 529 | 502 | 480 | 367 | 296 | 278 | 228 | 153 | 235 |
| Diluted EPS ($) | 10.30 | 9.70 | 7.97 | 6.98 | 6.63 | 3.88 | 4.78 | 3.83* | 2.89* | 2.43* | 2.29* | 2.21* | 1.72* | 1.47* | 1.46* | 1.22* | 0.83* | 1.29* |
| Diluted shares (millions) | 207 | 212 | 217 | 215 | 211 | 210 | 216 | 223* | 220* | 217* | 219* | 215* | 211* | 198* | 184* | 179* | 176* | 176* |
Balance sheet
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 25, 2025 | FY2024ended Sep 30, 2024filed Nov 26, 2024 | FY2023ended Sep 30, 2023filed Nov 21, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 23, 2021 | FY2020ended Sep 30, 2020filed Nov 24, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 21, 2018 | FY2017ended Sep 30, 2017filed Nov 22, 2017 | FY2016ended Sep 30, 2016filed Nov 22, 2016 | FY2015ended Sep 30, 2015filed Nov 25, 2015 | FY2014ended Sep 30, 2014filed Nov 25, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 21, 2012 | FY2011ended Sep 30, 2011filed Nov 23, 2011 | FY2010ended Sep 30, 2010filed Nov 24, 2010 | FY2009ended Sep 30, 2009filed Aug 6, 2010 | FY2008ended Sep 30, 2008filed Aug 6, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11,389 | 10,998 | 9,313 | 6,178 | 7,201 | 5,390 | 3,957 | 3,500 | 3,670 | 1,650 | 2,601 | 2,199 | 2,597 | 1,980 | 2,440 | 2,943 | 2,306 | 3,207 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | 88,230 | 82,992 | 78,360 | 80,951 | 61,891 | 47,482 | 38,830 | 37,413 | 34,883 | 31,487 | 26,468 | 23,326 | 23,186 | 21,160 | 18,007 | 17,883 | 18,227 | — |
| Total current liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | 1 | 8 | — | — | — | — | — | — | 1,191 | 1,195 | — | — | 356 | — | — |
| Total liabilities | 75,726 | 71,325 | 68,173 | 71,519 | 53,588 | 40,306 | 32,187 | 30,961 | 29,190 | 26,424 | 21,682 | 18,892 | 19,188 | 17,480 | 15,095 | 15,286 | 15,994 | — |
| Stockholders’ equity | 12,503 | 11,673 | 10,214 | 9,458 | 8,245 | 7,114 | 6,581 | 6,368 | 5,582 | 4,917 | 4,522 | 4,141 | 3,663 | 3,269 | 2,588 | 2,303 | 2,032 | — |
| Shares outstanding (millions) | 197 | 204 | 209 | 215 | 206 | 205* | 208* | 215* | 217* | 213* | 215* | 212* | 210* | 208* | 189* | 187* | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Sep 30, 2025filed Nov 25, 2025 | FY2024ended Sep 30, 2024filed Nov 26, 2024 | FY2023ended Sep 30, 2023filed Nov 21, 2023 | FY2022ended Sep 30, 2022filed Nov 22, 2022 | FY2021ended Sep 30, 2021filed Nov 23, 2021 | FY2020ended Sep 30, 2020filed Nov 24, 2020 | FY2019ended Sep 30, 2019filed Nov 26, 2019 | FY2018ended Sep 30, 2018filed Nov 21, 2018 | FY2017ended Sep 30, 2017filed Nov 22, 2017 | FY2016ended Sep 30, 2016filed Nov 22, 2016 | FY2015ended Sep 30, 2015filed Nov 25, 2015 | FY2014ended Sep 30, 2014filed Nov 25, 2014 | FY2013ended Sep 30, 2013filed Nov 26, 2013 | FY2012ended Sep 30, 2012filed Nov 21, 2012 | FY2011ended Sep 30, 2011filed Nov 23, 2011 | FY2010ended Sep 30, 2010filed Nov 24, 2010 | FY2009ended Sep 30, 2009filed Aug 6, 2010 | FY2008ended Sep 30, 2008filed Aug 6, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,434 | 2,155 | (3,514) | 72 | 6,647 | 4,073 | 577 | 884 | (125) | (573) | 899 | 508 | — | 391 | 1,558 | (1,021) | 374 | 227 |
| Capital expenditures | 188 | 205 | 173 | 91 | 74 | 124 | 138 | 134 | 190 | 122 | 74 | 60 | 73 | 78 | 37 | 22 | 36 | 51 |
| Free cash flow (CFO − capex) | 2,246 | 1,950 | (3,687) | (19) | 6,573 | 3,949 | 439 | 750 | (315) | (695) | 825 | 447 | — | 314 | 1,521 | (1,044) | 339 | 176 |
| Depreciation and amortization | 195 | 179 | 165 | 145 | 134 | 119 | 112 | 99 | 71 | 63 | 68 | 64 | 66 | 51 | 40 | 40 | 35 | 28 |
| Share repurchases | — | — | — | — | 128 | 272 | 778 | 62 | 34 | 163 | 89 | 8 | 12 | 21 | 23 | 4 | 4 | 67 |
| Dividends paid | — | — | — | — | 218 | 205 | 191 | 151 | 127 | 113 | 103 | 88 | 77 | 69 | 63 | 56 | 54 | 53 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Allaire Bella Loykhter | Chief Admin Officer | open-market sale | 7,500 | $177.60 | $1M | 46,086 | Aug 31, 2026 |
| Aug 20, 2026 | Helal Tarek | Chief Strategy Officer | gift | 23,397 | $0.00 | — | 48,537 | Aug 27, 2026 |
| Aug 20, 2026 | Helal Tarek | Chief Strategy Officer | gift | 23,397 | $0.00 | — | 25,140 | Aug 27, 2026 |
| Aug 18, 2026 | Curtis Scott A | Chief Operating Officer | gift | 1,000 | $0.00 | — | 191,418 | Aug 20, 2026 |
| Jul 28, 2026 | Elwyn Tashtego S | President, PCG | open-market sale | 10,000 | $176.06 | $2M | 45,114 | Jul 29, 2026 |
| Jul 27, 2026 | Raney Steven M | Executive Chair RJBank | open-market sale | 5,770 | $172.97 | $998K | 43,046 | Jul 28, 2026 |
| Mar 19, 2026 | Allaire Bella Loykhter | Chief Admin Officer | open-market sale | 29,551 | $142.34 | $4M | 53,586 | Mar 20, 2026 |
| Feb 28, 2026 | Aisenbrey Christopher S | Chief Human Resources Officer | option exercise | 600 | $0.00 | — | 17,622 | Mar 3, 2026 |
| Feb 28, 2026 | Aisenbrey Christopher S | Chief Human Resources Officer | tax withholding | 132 | $153.08 | $20K | 17,490 | Mar 3, 2026 |
| Feb 24, 2026 | Edwards Jeffrey N | Director | gift | 1,504 | $0.00 | — | 9,533 | Feb 25, 2026 |
| Feb 24, 2026 | Edwards Jeffrey N | Director | giftindirect | 1,504 | $0.00 | — | 22,008 | Feb 25, 2026 |
| Feb 19, 2026 | Seshadri Raj | Director | award | 1,303 | $0.00 | — | 13,782 | Feb 23, 2026 |
| Feb 19, 2026 | Mcdaniel Raymond W | Director | award | 1,303 | $0.00 | — | 6,113 | Feb 23, 2026 |
| Feb 19, 2026 | Mcgeary Roderick C | Director | award | 1,303 | $0.00 | — | 24,354 | Feb 23, 2026 |
| Feb 19, 2026 | Gates Anne | Director | award | 1,303 | $0.00 | — | 16,848 | Feb 23, 2026 |
| Feb 19, 2026 | Garcia Art A | Director | award | 1,303 | $0.00 | — | 6,992 | Feb 23, 2026 |
| Feb 19, 2026 | Esty Benjamin | Director | award | 1,303 | $0.00 | — | 31,794 | Feb 23, 2026 |
| Feb 19, 2026 | Mistarz Cecily | Director | option exercise | 250 | $0.00 | — | 3,992 | Feb 23, 2026 |
| Feb 19, 2026 | Mistarz Cecily | Director | award | 1,303 | $0.00 | — | 2,489 | Feb 23, 2026 |
| Feb 19, 2026 | Mistarz Cecily | Director | option exercise | 1,253 | $0.00 | — | 3,742 | Feb 23, 2026 |
| Feb 19, 2026 | Mistarz Cecily | Director | option exercise | 250 | $0.00 | — | 4,242 | Feb 23, 2026 |
| Feb 19, 2026 | Edwards Jeffrey N | Director | option exercise | 1,253 | $0.00 | — | 11,037 | Feb 23, 2026 |
| Feb 19, 2026 | Debel Marlene | Director | option exercise | 1,253 | $0.00 | — | 8,820 | Feb 23, 2026 |
| Feb 19, 2026 | Begor Mark W | Director | award | 1,303 | $0.00 | — | 2,285 | Feb 23, 2026 |
| Feb 4, 2026 | Santelli Jonathan N | EVP, General Counsel | open-market sale | 4,500 | $170.46 | $767K | 26,853 | Feb 5, 2026 |
Full insider history for Raymond James Financial, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 9; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- RAYMOND JAMES FINANCIAL, INC., CIK 720005 on EDGAR
- Extract generated
- October 6, 2026
- Withheld
- none
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenuesNetOfInterestExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsLongTermDebtLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationAmortizationAndAccretionNet, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated October 6, 2026.
- JSON file
/data/financials/RJF.json